Betta Pharmaceuticals Co Ltd Cash Flow-to-Debt Ratio
Betta Pharmaceuticals Co Ltd cash flow-to-debt ratio. Betta Pharmaceuticals Co Ltd (300558) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2025, meaning its operating cash flow of CN¥224.45 Million could theoretically repay 0% of its total liabilities (CN¥3.78 Billion) in one year. Check 300558 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Betta Pharmaceuticals Co Ltd (2011–2025)
Cash flow-to-debt ratio of Betta Pharmaceuticals Co Ltd from 2011 to 2025. Historical debt coverage capacity for Betta Pharmaceuticals Co Ltd across 15 annual periods. Check Betta Pharmaceuticals Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Betta Pharmaceuticals Co Ltd Cash Flow-to-Debt Ratio by Year (2011–2025)
Betta Pharmaceuticals Co Ltd cash flow-to-debt ratio by year from 2011 to 2025. Year-by-year debt coverage analysis for Betta Pharmaceuticals Co Ltd. For the full cash flow conversion analysis, see Betta Pharmaceuticals Co Ltd cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.23x | CN¥911.26 Million | CN¥3.90 Billion | ▼ -5.7% |
| 2024 | 0.25x | CN¥911.17 Million | CN¥3.68 Billion | ▲ +2.9% |
| 2023 | 0.24x | CN¥914.23 Million | CN¥3.80 Billion | ▲ +131.8% |
| 2022 | 0.10x | CN¥306.74 Million | CN¥2.95 Billion | ▼ -68.7% |
| 2021 | 0.33x | CN¥526.63 Million | CN¥1.59 Billion | ▼ -43.6% |
| 2020 | 0.59x | CN¥646.02 Million | CN¥1.10 Billion | ▲ +76.7% |
| 2019 | 0.33x | CN¥555.07 Million | CN¥1.66 Billion | ▲ +47.4% |
| 2018 | 0.23x | CN¥286.40 Million | CN¥1.27 Billion | ▼ -42.6% |
| 2017 | 0.39x | CN¥278.26 Million | CN¥706.48 Million | ▼ -76.9% |
| 2016 | 1.71x | CN¥407.05 Million | CN¥238.27 Million | ▲ +12.1% |
| 2015 | 1.52x | CN¥385.56 Million | CN¥253.09 Million | ▼ -34.2% |
| 2014 | 2.31x | CN¥277.55 Million | CN¥119.90 Million | ▲ +11.5% |
| 2013 | 2.08x | CN¥190.34 Million | CN¥91.71 Million | ▲ +23.0% |
| 2012 | 1.69x | CN¥149.29 Million | CN¥88.44 Million | ▲ +689.8% |
| 2011 | 0.21x | CN¥34.80 Million | CN¥162.83 Million | — |